Cargando…

Chinese Consensus Statement on the Evaluation and Intervention of Collateral Circulation for Ischemic Stroke

BACKGROUND: Collateral circulation is becoming more significant in the individual management strategy of ischemic stroke, there are more data updated recently. AIM: To make the further acknowledgment of the evaluation and how to improving collateral flow, for better treatment selection. METHOD: A pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Li‐Ping, Xu, An‐Ding, Wong, Lawrence K.S., Wang, David Z., Wang, Yong‐Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233984/
https://www.ncbi.nlm.nih.gov/pubmed/24495505
http://dx.doi.org/10.1111/cns.12226
Descripción
Sumario:BACKGROUND: Collateral circulation is becoming more significant in the individual management strategy of ischemic stroke, there are more data updated recently. AIM: To make the further acknowledgment of the evaluation and how to improving collateral flow, for better treatment selection. METHOD: A panel of experts on stroke providing related statement based on review the results from most up‐to‐date clinical research. RESULTS: DSA is the gold standard in evaluating all levels of collaterals. CTA can be used for evaluating leptomeningeal collaterals, MRA for CoW, TCD or TCCS can be used as screening tool for primary evaluation. The treatment modalities include direct interventions, such as Extracranial–Intracranial bypass, and indirect interventions, as External counterpulsation and pressor therapy. The consideration of methodology to augment and improve can be considered on an individual basis. DISCUSSION: In this consensus, we interpret the definition, neuroimaging evaluation, intervention and potential strategy on collaterals in the future. CONCLUSION: Assessment of collateral circulation is crucial for selecting therapeutic options, predicting infarction volume and making prognosis after ischemic stroke. Data is still needed to provide therapeutic evidence for many new developed technologies. Until more evidence is available, the clinical significance of applying the new technologies is unclear and perhaps limited.